ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Regeneron Pharmaceuticals
A Principal Applications Developer in the Regeneron Genetics Center IT group builds end-to-end engineering solutions that support large-scale genetic research. The role acts as a subject-matter expert driving technical strategy for high-performance application interfaces and enterprise data pipelines to enable fast, precise access to vast genetic datasets.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
MarketBeatQuadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
The Globe and MailIn 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Simply Wall StWill Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Seeking AlphaRegeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago